DoseMe

Houston, United States Founded: 2014 • Age: 12 yrs Acquired By Fairlong Capital
Precision dosing tools are provided for healthcare professionals.

About DoseMe

DoseMe is a Healthcare company based in Houston (United States) founded in 2014 by Robert McLeay, and was acquired by Fairlong Capital in January 2023. It operates as a precision dosing tools are provided for healthcare professionals. Its chief executive is Charles Cornish. Its website doseme-rx.com draws about 22 thousand monthly visits. DoseMe offers products and services including DoseMeRx Platform, Vancomycin Dosing Calculator, and Analytics and Integrations. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is DoseMe Pty Ltd. Its competitors include Ivenix, Hygieia, Assurex Health, InsightRx and GenXys and 3 more; 7 of its 8 listed competitors have raised funding.

Company details

DoseMe was founded in 2014 in Houston, United States, within the precision medicine sector. A platform is offered to doctors, enabling real-time pharmacokinetic measurements via electronic health records. Drug doses are calculated and compared, with customizations made for individual patients. HIPAA compliance is maintained, and integration with EHR systems is supported to aid drug optimization.

  • Headquarters Houston, United States
  • Founders Robert McLeay
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Pharmacy
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website doseme-rx.com
  • Social LinkedIn X Facebook
  • Acquired by Fairlong Capital (Jan 2023)
  • Legal Name Doseme Pty Ltd
Key Metrics

Products & Services of DoseMe

DoseMe offers a comprehensive portfolio of products and services, including DoseMeRx Platform, Vancomycin Dosing Calculator, and Analytics and Integrations.

DoseMeRx Platform
Dosing Software

Bayesian tool for accurate drug dosing and patient outcome optimization

Vancomycin Dosing Calculator
Calculation Tool

Specialized calculator for precise vancomycin dose adjustments

Analytics and Integrations
Support Features

Web-based tools for data analysis and system integration in healthcare

Investors in DoseMe

DoseMe has secured backing from 2 investors. Prominent investors backing the company include AnewHealth and Fairlong Capital.

All
InvestorDescriptionFounded YearDomainLocation
Cloud-based medication risk optimization solutions are provided for healthcare organizations.
2013tabularasahealthcare.comMoorestown, United States
-
–fairlongcapital.com-
Premium access

Investor details for DoseMe

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of DoseMe

11 people are tracked at DoseMe (7 in leadership, 4 in team).

NameRoleGroup
Robert McLeay
Founder & CSOLeadership
Charles Cornish
CEOLeadership
Michael N. Dorkhom
Chief Technology OfficerLeadership
Carolina Cornish
Chief Operations OfficerLeadership
Paul Edwards
President & Chief Executive OfficerLeadership
John Hardesky
VP & CCOLeadership
Sharmeen R.
Chief Strategy & Science OfficerLeadership
(MJ) - Michael Hopkins Jr
Senior Account ExecutiveTeam
Gayatri Awate
Product And QA ManagerTeam
Swarada Sohoni
Quality Assurance EngineerTeam
Alexander Santander
Software DeveloperTeam
Premium access

Complete people profiles for DoseMe

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of DoseMe

3 dated milestones of DoseMe across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded DoseMe is founded.
  2. Exit Acquired by Tabula Rasa Healthcare.
  3. Exit Acquired by Fairlong Capital.

Competitors of DoseMe

DoseMe has 8 listed competitors in our database, 7 of them funded. They include Ivenix, Hygieia, Assurex Health, InsightRx and GenXys, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ivenix.com2001Amesbury, United States$159.97M60
Infusion management systems are developed with wireless web-based architecture.
hygieia.com2007Ann Arbor, United States$8.79M17
Insulin dosage guidance for diabetes is provided via handheld devices.
assurexhealth.com2006Mason, United States$84.47M390
Personalized medication for neuropsychiatric conditions is guided by pharmacogenomics.
insight-rx.com2015San Francisco, United States$13.25M23
Precision dosing is optimized via machine learning and patient data.
genxys.com2014Vancouver, Canada$1.33M–
Provider of pharmacogenetic testing and a medication decision support system
vitagene.com2014San Francisco, United States$5.8M8
Personalized supplement recommendations are generated from genomic and health data.
medeye.com2010–$12.01M–
Medication safety platform for hospitals is provided online by MedEye.
curematch.com2015San Diego, United States––
CureMatch is focused on precision oncology solutions for cancer treatment.
Premium access

Detailed competitors of DoseMe

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of DoseMe

The website of DoseMe (doseme-rx.com) receives about 22.1K visits a month and ranks #1,436,763 among all websites worldwide, #2,262 in Pharmacy.

  • Monthly visits
    22.1K

    ▲ 14.5% vs previous month

  • Unique visitors
    8.6K

    per month

  • Global rank
    #1,436,763

    among all websites

  • Category rank
    #2,262

    Health · Pharmacy

Similar websites

Websites whose visitors overlap most with DoseMe. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bcrenal.ca
bcrenal.ca
100%
–#694,453–
europeanreview.org
europeanreview.org
94%
–#348,019–
dynamed.com
dynamed.com
94%
–#128,137–
bccdc.ca
bccdc.ca
94%
–#272,732–
sahealth.sa.gov.au
sahealth.sa.gov.au
94%
–#65,523–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for DoseMe

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as DoseMe (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about DoseMe

DoseMe was founded in 2014.

DoseMe is headquartered in Houston, United States. It is registered at Houston, Texas, United States.

Charles Cornish is the current CEO of DoseMe.

DoseMe was founded in 2014 in Houston, United States, within the precision medicine sector. A platform is offered to doctors, enabling real-time pharmacokinetic measurements via electronic health records. Drug doses are calculated and compared, with customizations made for individual patients. HIPAA compliance is maintained, and integration with EHR systems is supported to aid drug optimization.

DoseMe's top competitors include Assurex Health, Ivenix and Hygieia.

DoseMe offers DoseMeRx Platform, Vancomycin Dosing Calculator, and Analytics and Integrations.

DoseMe has 2 investors. Key investors include AnewHealth, and Fairlong Capital.

DoseMe operates through Doseme Pty Ltd.

Yes. DoseMe was acquired by Fairlong Capital in January 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available